Sam Fazeli brings with him over 22 years of experience conducting equity research as a pharmaceutical analyst.

Dr. Fazeli specializes in global pharmaceuticals.

e-Meet Dr. Fazeli at #Sachs_ELSF

More info @ https://t.co/YXBF2fUYBz pic.twitter.com/iOjnvOUNBL

— Sachs Associates (@SachsAssociates) January 27, 2021